Integer Holdings Corporation (NYSE:ITGR) Receives Average Rating of “Hold” from Brokerages

Shares of Integer Holdings Corporation (NYSE:ITGR) have been assigned an average rating of “Hold” from the eleven analysts that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have given a hold recommendation and four have given a buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $98.3750.

A number of equities research analysts have issued reports on the stock. Argus lowered shares of Integer from a “buy” rating to a “hold” rating in a report on Friday, October 24th. KeyCorp dropped their target price on shares of Integer from $145.00 to $133.00 and set an “overweight” rating for the company in a report on Tuesday, October 21st. Raymond James Financial restated an “outperform” rating and set a $95.00 price target (down previously from $143.00) on shares of Integer in a report on Friday, October 24th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Integer in a research report on Monday, December 29th. Finally, Citigroup lifted their price objective on Integer from $69.00 to $75.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th.

Insider Activity at Integer

In related news, Director Cheryl C. Capps purchased 1,600 shares of the firm’s stock in a transaction that occurred on Thursday, November 6th. The stock was bought at an average cost of $66.70 per share, with a total value of $106,720.00. Following the completion of the purchase, the director directly owned 11,702 shares in the company, valued at approximately $780,523.40. This represents a 15.84% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Diron Smith acquired 1,116 shares of the business’s stock in a transaction on Friday, November 7th. The shares were purchased at an average cost of $67.19 per share, for a total transaction of $74,984.04. Following the completion of the transaction, the executive vice president owned 7,698 shares in the company, valued at approximately $517,228.62. This represents a 16.96% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 2.16% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Integer

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ITGR. Salomon & Ludwin LLC purchased a new position in Integer during the third quarter valued at $26,000. Global Retirement Partners LLC increased its stake in shares of Integer by 293.8% in the 3rd quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock worth $33,000 after acquiring an additional 238 shares in the last quarter. CWM LLC lifted its position in Integer by 46.1% during the 2nd quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock valued at $44,000 after acquiring an additional 112 shares during the period. MAI Capital Management boosted its stake in Integer by 220.9% during the second quarter. MAI Capital Management now owns 369 shares of the medical equipment provider’s stock worth $45,000 after acquiring an additional 254 shares in the last quarter. Finally, Farther Finance Advisors LLC boosted its stake in Integer by 193.2% during the fourth quarter. Farther Finance Advisors LLC now owns 519 shares of the medical equipment provider’s stock worth $41,000 after acquiring an additional 342 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Stock Performance

Shares of ITGR stock opened at $86.87 on Friday. The company has a market capitalization of $3.04 billion, a P/E ratio of 36.35, a PEG ratio of 0.79 and a beta of 0.78. Integer has a fifty-two week low of $62.00 and a fifty-two week high of $144.76. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.45 and a current ratio of 3.71. The stock has a 50 day moving average price of $78.46 and a two-hundred day moving average price of $90.90.

Integer announced that its board has approved a stock buyback program on Tuesday, November 4th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the medical equipment provider to purchase up to 8.3% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its stock is undervalued.

More Integer News

Here are the key news stories impacting Integer this week:

• Negative Sentiment: Multiple firms announce a securities-fraud class action against Integer covering investors who bought shares between July 25, 2024 and October 22, 2025; plaintiffs allege misleading statements and seek lead plaintiff appointments. Integer Accused of Misleading Investors — GlobeNewswire
• Negative Sentiment: Numerous plaintiff firms (Rosen, Levi & Korsinsky, Bernstein Liebhard, Pomerantz, et al.) are soliciting lead plaintiff candidates and reminding investors of a February 9, 2026 deadline to file — increasing the likelihood of consolidated litigation and legal costs. Rosen Law Firm Deadline Notice — Newsfile
• Negative Sentiment: Lawyer notices link the litigation to a prior ~32% share plunge that triggered investor losses; that drop is the proximate cause for the suits and is cited repeatedly in firm announcements. Loss Notice: Plummeted 32% — Newsfile

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.